| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Across the last three months, Apogee Therapeutics, Inc.'s insiders have reduced their positions by a net 137,400 shares worth roughly $17.9M. In the past 30 days, 0 insiders bought and 1 sold.
Not all activity pointed one way: 1 insider sold in the same window, though they still hold shares. Classified under Biotechnology (Health Care sector), APGE's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 920.9K | $124.18M | - | |
| Other | 174.0K | $23.46M | -5,500 | |
| CFO | 158.4K | $21.35M | - | |
| Dir | 7.7K | $1.03M | - | |
| Dir | 7.7K | $1.03M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 1, 2025 | Dambkowski Carl47 | Chief Medical Officer | Sale+OE | 5,110 | $39.80 | $203,378.00 | -1.8% | +92.4% | - | |
| Sep 3, 2025 | Dambkowski Carl47 | Chief Medical Officer | Sell | 2,725 | $37.87 | $103,198.20 | -0.6% | +81.2% | - | |
| Aug 6, 2025 | Dambkowski Carl47 | Chief Medical Officer | Sell | 2,725 | $37.78 | $102,950.50 | -1.1% | +48.4% | - | |
| Jul 2, 2025 | Dambkowski Carl47 | Chief Medical Officer | Sale+OE | 10,090 | $45.09 | $454,954.04 | -1.4% | -10.4% | +199.9% | |
| Jun 4, 2025 | Dambkowski Carl47 | Chief Medical Officer | Sell | 2,725 | $36.96 | $100,716.00 | -1.1% | +3.7% | +149.0% | |
| May 7, 2025 | Dambkowski Carl47 | Chief Medical Officer | Sell | 2,725 | $35.75 | $97,418.75 | -1.1% | +8.8% | +132.2% | |
| Apr 2, 2025 | Dambkowski Carl47 | Chief Medical Officer | Sell | 3,860 | $36.22 | $139,801.27 | -0.5% | +17.0% | +122.9% | |
| Mar 5, 2025 | Dambkowski Carl47 | Chief Medical Officer | Sell | 1,590 | $30.48 | $48,463.20 | -0.6% | +18.0% | +125.8% | |
| Mar 5, 2025 | Henderson Michael Thomas57 | Chief Executive Officer | Sell | 10,000 | $30.15 | $301,511.36 | -0.4% | +18.0% | +125.8% | |
| Feb 5, 2025 | Dambkowski Carl47 | Chief Medical Officer | Sale+OE | 3,520 | $40.69 | $143,228.80 | -1.4% | -13.9% | +50.3% |